Tatiane Marcusso Orsini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tatiane Marcusso Orsini has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Allan Henrique Depieri Cataneo
Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University, Atlanta, GA 30322, USA
1 shared publication Ana Paula Fortes dos Santos Thomazelli
Department of Pathological Sciences, Center of Biological Sciences, State University of Londrina, 86057-970 Londrina, PR, Brazil
1 shared publication- Carolina Panis
Universidade Estadual do Oeste do Paraná
1 shared publication Danielle Kian
Department of Microbiology, Center of Biological Sciences, State University of Londrina, 86057-970 Londrina, PR, Brazil
1 shared publication- Fernanda Tomiotto-Pellissier
Department of Medical Pathology Federal University of Paraná Curitiba Paraná Brazil
1 shared publication - Florêncio Sousa Gouveia Júnior
Bioinorganic Group, Department of Organic and Inorganic Chemistry, Federal University of Ceará, Fortaleza, CE, 60451-970, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2016
- Published by Wiley in Mediators of Inflammation
- Vol. 2016, 1-10
Antileishmanial Activity and Inducible Nitric Oxide Synthase Activation by RuNO Complex
Parasites of the genusLeishmaniaare capable of inhibiting effector functions of macrophages. These parasites have developed the adaptive ability to escape host defenses; for example, they inactivate the NF-κB complex and suppress iNOS expression in infected macrophages, which are responsible for the production of the major antileishmanial substance nitric oxide (NO), favoring then its replication and successful infection. Metal complexes with NO have been studied as potential compounds for the treatment of certain tropical diseases, such as ruthenium compounds, known to be exogenous NO donors. In the present work, the compoundcis-[Ru(bpy)2SO3(NO)]PF6, or RuNO, showed leishmanicidal activity directly and indirectly on promastigote forms ofLeishmania (Leishmania) amazonensis. In addition, treatment with RuNO increased NO production by reversing the depletion of NO caused byLeishmania. We also found increased expression of Akt, iNOS, and NF-κB in infected and treated macrophages. These results demonstrated that RuNO was able to kill the parasite by NO release and modulate the transcriptional capacity of the cell.
- 1 January 2016
- Published by Wiley in Mediators of Inflammation
- Vol. 2016, 1-10
Open AccessAntileishmanial Activity and Inducible Nitric Oxide Synthase Activation by RuNO Complex
Parasites of the genusLeishmaniaare capable of inhibiting effector functions of macrophages. These parasites have developed the adaptive ability to escape host defenses; for example, they inactivate the NF-κB complex and suppress iNOS expression in infected macrophages, which are responsible for the production of the major antileishmanial substance nitric oxide (NO), favoring then its replication and successful infection. Metal complexes with NO have been studied as potential compounds for the treatment of certain tropical diseases, such as ruthenium compounds, known to be exogenous NO donors. In the present work, the compoundcis-[Ru(bpy)2SO3(NO)]PF6, or RuNO, showed leishmanicidal activity directly and indirectly on promastigote forms ofLeishmania (Leishmania) amazonensis. In addition, treatment with RuNO increased NO production by reversing the depletion of NO caused byLeishmania. We also found increased expression of Akt, iNOS, and NF-κB in infected and treated macrophages. These results demonstrated that RuNO was able to kill the parasite by NO release and modulate the transcriptional capacity of the cell.